BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu SH, Tsai WS, Chang YH, Chou TY, Pang ST, Lin PH, Tsai CM, Chang YC. Identifying cancer origin using circulating tumor cells. Cancer Biol Ther 2016;17:430-8. [PMID: 26828696 DOI: 10.1080/15384047.2016.1141839] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pellè E, Quaresmini D, Tucci M, Silvestris F. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol 2018;10:1758835918794630. [PMID: 30181785 DOI: 10.1177/1758835918794630] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 37.3] [Reference Citation Analysis]
2 Tsai Y, Yeh P, Huang C, Guo C, Chang Y. Scalable Multilayer Cell Collector to Capture Circulating Tumor Cells with an Unlimited Volume Capacity. ACS Biomater Sci Eng 2019;5:2725-31. [DOI: 10.1021/acsbiomaterials.9b00315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Liu K, Chen N, Wei J, Ma L, Yang S, Zhang X. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma. Oncol Rep 2020;43:1525-35. [PMID: 32323844 DOI: 10.3892/or.2020.7536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Conway AM, Mitchell C, Kilgour E, Brady G, Dive C, Cook N. Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the 'U' out of 'CUP'. Br J Cancer 2019;120:141-53. [PMID: 30580378 DOI: 10.1038/s41416-018-0332-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
5 Lai CH, Chang YC. Microfluidic Capture and Multiplex Immunofluorescence of Circulating Tumor Cells to Identify Cancer of Origin. Methods Mol Biol 2017;1634:1-19. [PMID: 28819837 DOI: 10.1007/978-1-4939-7144-2_1] [Reference Citation Analysis]
6 Alama A, Coco S, Vanni I, Grossi F. Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy". Int J Mol Sci 2017;18:E1309. [PMID: 28629197 DOI: 10.3390/ijms18061309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
8 Miccio L, Cimmino F, Kurelac I, Villone MM, Bianco V, Memmolo P, Merola F, Mugnano M, Capasso M, Iolascon A, Maffettone PL, Ferraro P. Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips. View 2020;1:20200034. [DOI: 10.1002/viw.20200034] [Cited by in Crossref: 17] [Article Influence: 8.5] [Reference Citation Analysis]
9 Bedin C, Crotti S, D'Angelo E, D'Aronco S, Pucciarelli S, Agostini M. Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy. Curr Med Chem 2020;27:4274-94. [PMID: 31060482 DOI: 10.2174/0929867326666190507084839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Karunakaran KB, Yanamala N, Boyce G, Becich MJ, Ganapathiraju MK. Malignant Pleural Mesothelioma Interactome with 364 Novel Protein-Protein Interactions. Cancers (Basel) 2021;13:1660. [PMID: 33916178 DOI: 10.3390/cancers13071660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rassy E, Zanaty M, Azoury F, Pavlidis N. Advances in the management of brain metastases from cancer of unknown primary. Future Oncol 2019;15:2759-68. [PMID: 31385529 DOI: 10.2217/fon-2019-0108] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Chen L, Bode AM, Dong Z. Circulating Tumor Cells: Moving Biological Insights into Detection. Theranostics 2017;7:2606-19. [PMID: 28819450 DOI: 10.7150/thno.18588] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
13 Lai C, Choon Lim S, Wu L, Wang C, Tsai W, Wu H, Chang Y. Site-specific antibody modification and immobilization on a microfluidic chip to promote the capture of circulating tumor cells and microemboli. Chem Commun 2017;53:4152-5. [DOI: 10.1039/c7cc00247e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
14 Wang SG, Zhang B, Li CG, Zhu JQ, Sun BS, Wang CL. Sorting and gene mutation verification of circulating tumor cells of lung cancer with epidermal growth factor receptor peptide lipid magnetic spheres. Thorac Cancer 2020;11:2887-95. [PMID: 32856417 DOI: 10.1111/1759-7714.13625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Tsai WS, Chen JS, Shao HJ, Wu JC, Lai JM, Lu SH, Hung TF, Chiu YC, You JF, Hsieh PS, Yeh CY, Hung HY, Chiang SF, Lin GP, Tang R, Chang YC. Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients. Sci Rep 2016;6:24517. [PMID: 27075165 DOI: 10.1038/srep24517] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
16 González I, Earl J, Fernández LJ, Sainz B, Pinto A, Monge R, Alcalá S, Castillejo A, Soto JL, Carrato A. A Label Free Disposable Device for Rapid Isolation of Rare Tumor Cells from Blood by Ultrasounds. Micromachines (Basel) 2018;9:E129. [PMID: 30424062 DOI: 10.3390/mi9030129] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
17 Wu F, Gu Y, Kang B, Heskia F, Pachot A, Bonneville M, Wei P, Liang J. PD-L1 detection on circulating tumor-derived extracellular vesicles (T-EVs) from patients with lung cancer. Transl Lung Cancer Res 2021;10:2441-51. [PMID: 34295653 DOI: 10.21037/tlcr-20-1277] [Reference Citation Analysis]
18 Sut TN, Yoon BK, Jeon W, Jackman JA, Cho N. Supported lipid bilayer coatings: Fabrication, bioconjugation, and diagnostic applications. Applied Materials Today 2021;25:101183. [DOI: 10.1016/j.apmt.2021.101183] [Reference Citation Analysis]
19 Luo YT, Cheng J, Feng X, He SJ, Wang YW, Huang Q. The viable circulating tumor cells with cancer stem cells feature, where is the way out? J Exp Clin Cancer Res 2018;37:38. [PMID: 29482576 DOI: 10.1186/s13046-018-0685-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
20 Liu J, Cai J, Chen H, Zhang S, Kong J. A label-free impedimetric cytosensor based on galactosylated gold-nanoisland biointerfaces for the detection of liver cancer cells in whole blood. Journal of Electroanalytical Chemistry 2016;781:103-8. [DOI: 10.1016/j.jelechem.2016.10.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
21 Laprovitera N, Riefolo M, Ambrosini E, Klec C, Pichler M, Ferracin M. Cancer of Unknown Primary: Challenges and Progress in Clinical Management. Cancers (Basel) 2021;13:451. [PMID: 33504059 DOI: 10.3390/cancers13030451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Shoda K, Saito R, Maruyama S, Furuya S, Akaike H, Kawaguchi Y, Amemiya H, Kawaida H, Sudo M, Inoue S, Kono H, Ichikawa D. Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature. Surg Today 2021;51:849-61. [PMID: 32979121 DOI: 10.1007/s00595-020-02148-7] [Reference Citation Analysis]
23 Chen JY, Chang YC. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells. Adv Exp Med Biol 2017;994:43-66. [PMID: 28560667 DOI: 10.1007/978-3-319-55947-6_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
24 Benderra MA, Ilié M, Hofman P, Massard C. [Standard of care of carcinomas on cancer of unknown primary site in 2016]. Bull Cancer 2016;103:697-705. [PMID: 27372228 DOI: 10.1016/j.bulcan.2016.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
25 Choi SY, Lim B, Kyung YS, Kim Y, Kim BM, Jeon BH, Park JC, Sohn YW, Lee JH, Uh JH, Jang S, Kim CS. Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance. In Vivo 2019;33:1615-20. [PMID: 31471413 DOI: 10.21873/invivo.11645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Maly V, Maly O, Kolostova K, Bobek V. Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer. In Vivo 2019;33:1027-37. [PMID: 31280190 DOI: 10.21873/invivo.11571] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
27 Chen C, Yang L, Rivandi M, Franken A, Fehm T, Neubauer H. Bioinformatic Identification of a Breast-Specific Transcript Profile. Proteomics Clin Appl 2020;14:e2000007. [PMID: 32558282 DOI: 10.1002/prca.202000007] [Reference Citation Analysis]
28 Lowe AC. Circulating Tumor Cells: Applications in Cytopathology. Surg Pathol Clin 2018;11:679-86. [PMID: 30190148 DOI: 10.1016/j.path.2018.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Lai C, Tsai W, Yang M, Chou T, Chang Y. A two-dimensional immunomagnetic nano-net for the efficient isolation of circulating tumor cells in whole blood. Nanoscale 2019;11:21119-27. [DOI: 10.1039/c9nr06256d] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
30 Jia M, Mao Y, Wu C, Wang S, Zhang H. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy. Anal Chim Acta 2019;1082:136-45. [PMID: 31472702 DOI: 10.1016/j.aca.2019.07.051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
31 Viswanath B, Kim S. Recent insights into the development of nanotechnology to detect circulating tumor cells. TrAC Trends in Analytical Chemistry 2016;82:191-8. [DOI: 10.1016/j.trac.2016.05.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]